Impax Laboratories (IPXL) reported earnings Mon 9 Nov 2015 (before open)

** charts after earnings **

 Reported Q3 (Sep) earnings of $0.40 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus of $0.39; revenues rose 39.9% year/year to $221.1 mln vs the $214.1 mln Capital IQ Consensus; lowered FY15 CapEx guidance, reaffirmed gross margin, R&D, other metric projections.